Liang BA*, & Mackey TK, Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics. J Med Internet Res. 2012 Feb 9;14(1):e27.

ABSTRACT 

Background: Unprecedented drug shortages announced by the US Food and Drug Administration (FDA) have severely affected therapeutic access, patient safety, and public health. With continued shortages, patients may seek drugs online.

Objective: To assess the prevalence of online marketing for current FDA shortage drugs and potential patient safety risks.

Methods: We performed a descriptive study of the prevalence of online marketing for shortage drugs—that is, offers for sale of each drug, including characteristics of online drug sellers and intermediary sites marketing these drugs.

Results: Of the 72 FDA shortage-listed drugs, 68 (94%) were offered for sale online. We found 291 offers for these drugs, the vast majority (n = 207, 71.1%) by online drug sellers selling direct to consumers. Intermediary sites included data aggregators (n = 22, 8%), forum links (n = 23, 8%), and personal page data links (n = 34, 12%), as well as Flickr social media links (n = 5, 2%), all advertising drugs without a prescription. Of the 91 online drug sellers identified, 31 (34%) had more than 1 shortage drug offered for sale, representing most (n = 148, 71%) of all online drug seller sales offers. The majority of these online drug sellers (n = 21, 68%) were on the National Association of Boards of Pharmacy (NABP) Not Recommended Sites list. Finally, for shortage drugs with an online drug seller (n = 58, 85%), 53 (91%) had at least one site on the Not Recommended list and 21 (36%) had only sites on the Not Recommended list.

Conclusions: FDA shortage drugs are widely marketed over the Internet. Suspect online drug sellers and intermediaries dominate these sales offers. As a critical risk management issue, patients, providers, and policymakers should be extremely cautious in procuring shortage drugs through Internet sourcing.

Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics.  

|


Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!

 Email:


2014 Interchange Save the Date

The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
Learn the secrets!


Report Counterfeit and Black Market Medicines

Track & Trace legislation
President Obama signed into law, on November 27, 2013, legislation to enhance the safety of the drug supply chain, which has seen a number of incidents in recent years threaten American patients.   Learn more>>


Get Breaking News

 

Youtube  Follow Us on Twitter Like us on Facebook Flickr Delicious Stumble Upon Tumblr

Drug Safety Alert

FDA warns consumers about potential health risks from using Thorne Research’s Captomer products (June 12)

counterfeit drug alerts to tweet Tweet this alert!

Counterfeit Drug Incident Encyclopedia

counterfeit drug incident encyclopedia banner